Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered significant attention in recent years for the effectiveness in weight management. Originally developed for the treating type 2 diabetes, semaglutide functions by mimicking the consequences of the GLP-1 hormone, which regulates appetite and food intake. The drug functions slowing gastric emptying, promoting a sense of...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian